FDA Determines A “Class Effect” Is In Play For All NSAIDs

An FDA decision to request revised safety labeling changes to OTC NSAIDs enables manufacturers to continue positioning the drugs as safer alternatives to their prescription counterparts, which will carry "black box" warnings going forward